Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.

Dana M RoqueEric R SiegelNatalia BuzaStefania BelloneDan-Arin SilasiGloria Shining HuangVaagn AndikyanMitchell ClarkMasoud AzodiPeter E SchwartzGautam G RaoJocelyn C ReaderPei HuiJoan R Tymon-RosarioJustin HaroldDennis MauricioBurak ZeybekGulden MenderesGary AltwergerElena RatnerAlessandro D Santin

Published in: British journal of cancer (2022)

NCT3093155.

Keyphrases

open label
papillary thyroid
clinical trial
placebo controlled
squamous cell
double blind
study protocol
lymph node metastasis
childhood cancer